<DOC>
	<DOCNO>NCT01282372</DOCNO>
	<brief_summary>Treatment tumor necrosis factor ( TNF ) inhibitor , especially adalimumab , demonstrated improvement work productivity participant rheumatic disease : rheumatoid arthritis ( RA ) , psoriatic arthritis ( PsA ) , ankylose spondylitis ( AS ) . Limited data available effect adalimumab treatment sleep three disease ( RA , PsA , AS ) data available effect adalimumab treatment work productivity PsA . This long term Health-Related Quality Life ( HRQL ) observational study conduct evaluate effect treatment adalimumab work productivity sleep disturbance Greek participant moderate severe rheumatic disease ( RA , PsA , AS ) .</brief_summary>
	<brief_title>Greek Study Work Productivity Sleep Patients With Rheumatic Diseases Treated With Adalimumab</brief_title>
	<detailed_description>This multi-center , uncontrolled , prospective , observational study participant moderate severe rheumatic disease ( RA , PsA , AS ) receive adalimumab normal clinical practice accordance Summary Product Characteristics ( SmPC ) , without anti-rheumatic treatment .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>1 . Participants moderate severe active rheumatic disease , receive adalimumab normal clinical practice accordance approve local SmPC . 2 . Participants provide consent data collection use AbbVie . 1 . Contraindications accord SmPC . 2 . Participants participate observational study conduct Abbvie .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Ankylosing spondylitis</keyword>
	<keyword>Sleep</keyword>
	<keyword>Psoriatic arthritis</keyword>
	<keyword>Work Productivity</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>